JP2018118936A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018118936A5 JP2018118936A5 JP2017012594A JP2017012594A JP2018118936A5 JP 2018118936 A5 JP2018118936 A5 JP 2018118936A5 JP 2017012594 A JP2017012594 A JP 2017012594A JP 2017012594 A JP2017012594 A JP 2017012594A JP 2018118936 A5 JP2018118936 A5 JP 2018118936A5
- Authority
- JP
- Japan
- Prior art keywords
- polyethylene glycol
- enteric
- solid preparation
- layer
- granule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008187 granular material Substances 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 239000002202 Polyethylene glycol Substances 0.000 claims 3
- 239000012055 enteric layer Substances 0.000 claims 3
- 229920001223 polyethylene glycol Polymers 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 3
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 claims 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 2
- 235000010355 mannitol Nutrition 0.000 claims 2
- 229940068918 Polyethylene Glycol 400 Drugs 0.000 claims 1
- 229940093429 Polyethylene Glycol 6000 Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 239000010410 layer Substances 0.000 claims 1
- 239000006191 orally-disintegrating tablet Substances 0.000 claims 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 claims 1
- 230000003482 proton pump inhibitor Effects 0.000 claims 1
- 239000000612 proton pump inhibitor Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017012594A JP7064683B2 (ja) | 2017-01-27 | 2017-01-27 | 腸溶層破損防止用組成物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017012594A JP7064683B2 (ja) | 2017-01-27 | 2017-01-27 | 腸溶層破損防止用組成物 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2018118936A JP2018118936A (ja) | 2018-08-02 |
JP2018118936A5 true JP2018118936A5 (ru) | 2020-03-05 |
JP7064683B2 JP7064683B2 (ja) | 2022-05-11 |
Family
ID=63042993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017012594A Active JP7064683B2 (ja) | 2017-01-27 | 2017-01-27 | 腸溶層破損防止用組成物 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7064683B2 (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2020055755A (ja) * | 2018-09-28 | 2020-04-09 | 日本ケミファ株式会社 | 腸溶性製剤 |
WO2020218517A1 (ja) * | 2019-04-25 | 2020-10-29 | 富士製薬工業株式会社 | 医薬製剤およびその製造方法 |
JP2021046372A (ja) * | 2019-09-19 | 2021-03-25 | 日医工株式会社 | エソメプラゾール含有製剤 |
US20230058473A1 (en) * | 2020-01-27 | 2023-02-23 | Towa Pharmaceutical Co., Ltd. | Esomeprazole oral preparation and method for producing the same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1121103B1 (en) | 1998-05-18 | 2006-12-20 | Takeda Pharmaceutical Company Limited | Orally disintegrable tablets comprising a benzimidazole |
US6749867B2 (en) | 2000-11-29 | 2004-06-15 | Joseph R. Robinson | Delivery system for omeprazole and its salts |
WO2004071374A2 (en) | 2003-02-11 | 2004-08-26 | Torrent Pharmaceuticals Limited | Once a day orally administered pharmaceutical compositions |
CN1263450C (zh) | 2005-01-20 | 2006-07-12 | 北京科信必成医药科技发展有限公司 | 奥美拉唑及其衍生物的口腔崩解片及其制备工艺 |
CN101646421A (zh) | 2007-04-26 | 2010-02-10 | 卫材R&D管理有限公司 | 片剂的制备方法 |
WO2008140459A1 (en) | 2007-05-16 | 2008-11-20 | Fmc Corporation | Solid form |
EP2044932A1 (en) | 2007-10-04 | 2009-04-08 | Laboratorios del Dr. Esteve S.A. | Mechanical protective layer for solid dosage forms |
-
2017
- 2017-01-27 JP JP2017012594A patent/JP7064683B2/ja active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2018118936A5 (ru) | ||
JP2017105763A5 (ru) | ||
JP2021509912A5 (ru) | ||
EA201390814A1 (ru) | Перорально распадающаяся таблетка | |
JP2016029697A5 (ru) | ||
CL2013001793A1 (es) | Comprimido de desintegracion oral de liberacion controlada que comprende i) granulos que contienen lanzoprazol y una capa de recubrimiento que comprende un copolimero y ii) granulos que comprenden lanzoprazol y una capa de recubrimiento que comprende un copolimero y un polimero, con granulos de tamaño medio de no mas de 500 µm. | |
CL2007001992A1 (es) | Compuestos derivados de pirimidilciclopentanos; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodege | |
JP2015005731A5 (ja) | 酸化物半導体膜 | |
CR20160192A (es) | Formulación de farmaco de liberación retardada | |
JP2018003122A5 (ru) | ||
EA201800232A1 (ru) | Двухосноориентированные пленки, изготовленные из композиций пропиленового полимера | |
EA201690679A1 (ru) | Стабильная фармацевтическая композиция, содержащая амлодипин и валсартан | |
DK3793534T3 (da) | Oral tablet til levering af aktive ingredienser til mavetarmkanalen | |
JP2013231052A5 (ru) | ||
JP2016540026A5 (ru) | ||
ES2623281T3 (es) | Composiciones farmacéuticas sólidas con recubrimiento entérico para inhibidores de la bomba de protones. | |
JP2018041788A5 (ru) | ||
CL2018000246A1 (es) | Tableta | |
RU2015140119A (ru) | Таблетка, покрытая кишечнорастворимым покрытием | |
GEP201706743B (en) | Oral formulation for the treatment of cardiovascular diseases | |
JP2015129175A5 (ru) | ||
JP2019513026A5 (ru) | ||
Utkewicz et al. | Epistaxis complicated by rivaroxaban managed with topical tranexamic acid | |
JP2016013980A5 (ru) | ||
JP2019518052A5 (ru) |